Clinical Trials on CD34 Selected Peripheral Blood Stem Cell Graft

Total 1243 results

Memorial Sloan Kettering Cancer Center

Completed

A Study to Assess Thymic Function Using PET/CT and MRI

CD34 Selected Peripheral Blood Stem Cell Graft

United States
National Cancer Institute (NCI)

Recruiting

The Lowest Effective Dose of Post-Transplantation Cyclophosphamide in Combination With Sirolimus and Mycophenolate Mofetil as Graft-Versus-Host Disease Prophylaxis After Reduced Intensity Conditioning and Peripheral Blood Stem Cell Transplantation

Hematopoietic Stem Cell Transplantation | Peripheral Blood Stem Cell Transplantation

United States
University of Florida
American Cancer Society, Inc.

Completed

Comparison of Gut Microbiota, Inflammation and Symptoms Following Allogeneic HSCT

Hematopoietic Stem Cell Transplantation | Graft vs Host Disease | Graft Versus Host Disease | Peripheral Blood Stem Cell Transplantation

United States
Jennifer E. Schwartz
Millennium Pharmaceuticals, Inc.

Completed

A Study Using Tacrolimus, Sirolimus and Bortezomib as Acute Graft Versus Host Disease (GVHD) Prophylaxis in Allogeneic Peripheral Blood Stem Cell (PBSC) Transplantation

Graft vs Host Disease | Peripheral Blood Stem Cell Transplantation | Transplantation, Homologous

United States
DKMS gemeinnützige GmbH

Recruiting

GvHD Prophylaxis in Unrelated Donor HCT: Randomized Trial Comparing PTCY Versus ATG (GRAPPA)

AML | MDS | Peripheral Blood Stem Cell Transplantation | Graft Vs Host Disease | CMML | MDS/MPN

Germany
Nanfang Hospital of Southern Medical University
Peking University People's Hospital; Sun Yat-sen University; Guangzhou First... and other collaborators

Unknown

Mesenchymal Stem Cells for Treatment of Poor Graft Function After Allogeneic Hematopoietic Stem Cell Transplant

Mesenchymal Stem Cells | Hematological Diseases | Stem Cell Transplantation, Hematopoietic | Poor Graft Function

China
Nanfang Hospital of Southern Medical University
Peking University People's Hospital; Sun Yat-sen University; Guangzhou First... and other collaborators

Unknown

Mesenchymal Stem Cells Combined With Cord Blood for Treatment of Graft Failure

Mesenchymal Stem Cells | Hematopoietic Stem Cell Transplantation | Hematological Diseases | Graft Failure | Umbilical Cord Blood

China
Gesellschaft fur Medizinische Innovation - Hamatologie...
ClinAssess GmbH; Deutsche Klinik fuer Diagnostik

Completed

PhaseII,Open-label,Pilot Study Evaluating the Safety+Efficacy of Certican ® in the Prevention of Chronic Graft-versus-host Disease+Late Pulmonary Complications After Allogeneic Hematopoietic Cell Transplantation Blood

Condition After Allogenic Peripheral Stem Cell Transplantation (SCT)

Germany
Kyowa Kirin Co., Ltd.

Completed

KRN125 for Mobilization of Hematopoietic Stem Cells

Peripheral Blood Stem Cell Transplantation

Japan
Peking University People's Hospital

Unknown

Second Transplantation for Graft Failure

Graft Failure | Stem Cell Transplant Complications

China
National Institutes of Health Clinical Center (CC)

Completed

Effects of Stem Cell Transplantation on Bacteria in the Mouth

Allogeneic Peripheral Blood Stem Cell Transplant

United States
Chinese PLA General Hospital

Unknown

Prophylactic Donor Lymphocyte Infusion After Allo-PBSCT for Patients With Very High-risk Hematologic Malignancies

Peripheral Blood Stem Cell Transplantation | Relapse | Donor Lymphocyte Infusion | Graft-versus-host Disease | Decitabine

China
Memorial Sloan Kettering Cancer Center

Terminated

T-cell Depleted Hematopoietic Stem Cell Boosts Without Conditioning for Poor Marrow Graft Function Following Allogeneic Hematopoietic Stem Cell Transplantation

Hematopoietic Stem Cell Transplant | Poor Marrow Graft Function

United States
Mayo Clinic

Withdrawn

Analysis of Biomarkers for Acute Graft-versus-Host Disease (GVHD)

Blood Stem Cell Transplant Failure

United States
University of Kansas Medical Center

Completed

Pilot Study: Patients With Chronic Active Graft Versus Host Disease That Have Failed or Not Tolerated Standard Therapy.

Graft Versus Host Disease | Blood Stem Cell Transplant Failure

United States
Imperial College London

Withdrawn

CD56+CD3- NK Cells Following Allogeneic Stem Cell Transplantation

Allogeneic Stem Cell Transplant | Haematological Malignancies | CD56+CD3- NK Cells

United Kingdom
Assistance Publique - Hôpitaux de Paris

Not yet recruiting

Haploidentical Allogeneic Hematopoietic Stem Cell Transplantation With Post-transplant Cyclophosphamide for Rescuing Patients With Graft Failure (HaploRescue)

Hematologic Diseases | Allogeneic Hematopoietic Stem Cell Transplantation | Graft Failure
National Institute of Mental Health (NIMH)

Completed

An Exploratory Study of the Characteristics of and Challenges for International Families Seeking Medical Care in the United States

Cancer | Bone Marrow Transplantation | Allogeneic Peripheral Blood Stem Cell Transplant

United States
Chinese PLA General Hospital

Recruiting

Ruxolitinib and Chidamide Intensified Bu/CY Conditioning Regimen

Peripheral Blood Stem Cell Transplantation

China
Peking University People's Hospital

Completed

G-CSF Moblized Peripheral Harvest for Poor Engraftment After Stem Cell Transplantation

Stem Cell Transplantation | Graft Versus Host Disease | Poor Graft Function

China
Imperial College Healthcare NHS Trust

Completed

Nutrition and Outcomes of Hematopoietic Cell Transplantation (HCT)

Hematologic Malignancy | Graft Versus Host Disease | Allogeneic Stem Cell Transplant | Stem Cell Transplant Complications
Alberta Health services

Completed

ACB A Randomized Study of 2.5ug/kg/Day vs. 5ug/kg/Day Dose of G-CSF After High Dose Chemotherapy Followed by Autologous Peripheral Blood Stem Cell/Marrow Transplant Recipients FILE#17159

Peripheral Stem Cell/Marrow Transplant

Canada
Nanfang Hospital of Southern Medical University
Peking University People's Hospital; Sun Yat-sen University; Shanghai Zhongshan... and other collaborators

Unknown

Peripheral Blood Stem Cell Combined With Mesenchymal Stem Cells for Treatment of Poor Graft Function

Hematological Diseases | Stem Cell Transplantation, Hematopoietic | Poor Graft Function

China
Centre Hospitalier Universitaire de Besancon

Recruiting

Lipopolysaccharide Metabolism and Identification of Potential Biomarkers Predictive of Graft-versus-host Disease After Allogeneic Stem Cell Transplantation (MetAlloLip)

Hematologic Diseases | Stem Cell Transplantation

France
National Institutes of Health Clinical Center (CC)
National Heart, Lung, and Blood Institute (NHLBI)

Terminated

Evaluation of Budesonide and How It Interacts With Antifungal Drugs in People With Gastrointestinal Graft-Versus-Host Disease

Stem Cell Transplantation | Graft vs Host Disease

United States
Hadassah Medical Organization

Completed

Thymoglobuline in Non-myeloablative Allogeneic Stem-cell Transplantation

Stem Cell Transplantation | Graft Vs Host Disease

Israel
Phillip Brian Smith
Eunice Kennedy Shriver National Institute of Child Health and Human Development...

Completed

Voriconazole Pharmacokinetics in Children With Gastrointestinal Graft Versus Host Disease

Stem Cell Transplantation | Graft Versus Host Disease

United States
China Medical University Hospital

Unknown

The Polarization and Expression of Chemokine Receptors of T Help Cell in the Pathogenesis of Acute and Chronic GVHD

Hematopoietic Stem Cell Transplantation, Graft-Versus-Host Disease
Shanghai Jiao Tong University School of Medicine
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine

Unknown

Valproic Acid With Methylprenisonlone for the Treatment of Acute GVHD

Peripheral Blood Stem Cell Transplantation | aGVHD

China
Medical University of Vienna

Unknown

Endomicroscopy and Graft-versus-host Disease

Haematopoietic Stem Cell Transplantation

Austria
Assistance Publique - Hôpitaux de Paris
Agence de La Biomédecine

Completed

Cyclosporine Dose Adjustment According to Calcineurin Activity After Allogeneic Hematopoietic Stem-cell Transplantation (CALCICLO)

Hematopoietic Stem Cell Transplantation | Graft Versus Host Disease

France
Ann & Robert H Lurie Children's Hospital of Chicago

Unknown

Extracorporeal Photopheresis for Acute Graft Versus Host Disease

Cancer | Stem Cell Transplantation | Graft Versus Host Disease

United States
Abramson Cancer Center of the University of Pennsylvania

Completed

Maraviroc in Patients Undergoing Non-Myeloablative Allogeneic Stem-Cell Transplantation

Hematopoietic Stem Cell Transplantation | Graft-versus-host Disease
BioLineRx, Ltd.

Completed

A Phase I Study Evaluating Safety, Tolerability, PK and PD of BL-8040 for Stem Cell Mobilization in Healthy Volunteers

Mobilization of Hematopoietic Stem Cells (HSC) to Peripheral Blood (PB)

Israel
Hospital Authority, Hong Kong
Hoffmann-La Roche

Unknown

Mycophenolate Mofetil for the Prophylaxis of Graft-versus-host Disease in High Risk Allogeneic Stem Cell Transplantation

Hematopoietic Stem Cell Transplantation | Graft vs Host Disease

China
Sherif S. Farag

Completed

Sitagliptin for Prevention of Acute Graft Versus-Host Disease After Allogeneic Hematopoietic Stem Cell Transplantation

Hematopoietic Stem Cell Transplantation | Graft vs Host Disease

United States
Affiliated Hospital to Academy of Military Medical...

Unknown

Maraviroc-Based GVHD Prophylaxis in HLA-Unrelated and HLA-Mismatched Related Transplantation

Hematopoietic Stem Cell Transplantation | Graft-versus-host Disease

China
William R. Drobyski, MD

Completed

A Study of Tacrolimus/Methotrexate and Tocilizumab to Prevent Acute Graft-Versus-Host Disease (AGVD) After Allogeneic Hematopoietic Stem Cell Transplant

Hematopoietic Stem Cell Transplantation

United States
Indiana University

Completed

A Multicenter Phase I Study Evaluating the Addition of Bortezomib to an Established Acute Graft Versus Host Disease Prophylaxis Regimen in Pediatric Allogeneic Hematopoietic Stem Cell Transplant Patients

Hematopoetic Stem Cell Transplant

United States
Hospital Authority, Hong Kong
Novartis Pharmaceuticals; The Hong Kong Blood Cancer Foundation

Unknown

Basiliximab for the Treatment of Acute Graft-versus-host Disease After Allogeneic Stem Cell Transplantation

Hematopoietic Stem Cell Transplantation | Graft vs Host Disease

China
Washington University School of Medicine
Cellect Biotechnology

Terminated

ApoGraft for the Prevention of Acute Graft Versus Host Disease in Haploidentical Hematopoietic Cell Transplant Recipients

Acute Graft Versus Host Disease | Haploidentical Hematopoietic Stem Cell Transplant

United States
Millennium Pharmaceuticals, Inc.

Terminated

A Dose-Finding Study of Vedolizumab for Treatment of Steroid-Refractory Acute Intestinal Graft-Versus-Host Disease (GvHD) in Participants Who Have Undergone Allogeneic Hematopoietic Stem Cell Transplantation (Allo-HSCT)

Allogeneic Hematopoietic Stem Cell Transplantation

United States, Belgium, Sweden, France, Norway
University of Cologne

Unknown

Changes in the Gut Microbiota of Patients Undergoing Allogeneic Stem Cell Transplantation (COLLECT) (COLLECT)

Acute Myeloid Leukemia | Allogeneic Hematopoietic Stem Cell Transplantation | Stem Cell Transplant Complications | Graft-versus-host-disease

Germany
Centre Hospitalier Universitaire, Amiens

Unknown

Analysis of Transcriptomic Profile of Graft-versus-host Disease (GHVD) After Allogeneic Grafting of Hematopoietic Stem Cells

Graft Vs Host Disease | Hematopoietic Stem Cells

France
Mehdi Hamadani

Completed

MLN9708 for the Prophylaxis of Chronic Graft-versus-host Disease in Patient Undergoing Allogeneic Transplantation

Allogeneic Hematopoietic Stem Cell Transplantation

United States
Ohio State University Comprehensive Cancer Center

Recruiting

Assessment of MicroRNA Expression in Acute Graft-versus-Host Disease

Acute Graft-versus-Host Disease | Allogeneic Stem Cell Transplant

United States
Nanfang Hospital of Southern Medical University
Peking University People's Hospital; Sun Yat-sen University; Guangzhou First... and other collaborators

Unknown

MSCs With or Without Peripheral Blood Stem Cell for Treatment of Poor Graft Function and Delayed Platelet Engraftment

Hematological Diseases | Stem Cell Transplantation, Hematopoietic | Delayed Platelet Engraftment | Poor Graft Function

China
University of Pisa

Recruiting

Tacrolimus Blood Concentration and Transplant-related Outcomes in Pediatric HSCT Recipients

Graft Vs Host Disease | Stem Cell Transplant Complications | Transplant Failure

Italy
The First Affiliated Hospital of Soochow University
The First Affiliated Hospital with Nanjing Medical University; Shenzhen People... and other collaborators

Recruiting

Sitagliptin for Prevention of aGVHD After Alternative Donor Transplantation

Allogeneic Hematopoietic Stem Cell Transplantation | Acute-graft-versus-host Disease

China
Oncoimmune, Inc., a subsidiary of Merck & Co.,...
National Cancer Institute (NCI); University of Michigan Rogel Cancer Center; Ohio... and other collaborators

Completed

Phase II Trial of Efprezimod Alfa (CD24Fc, MK-7110) for the Prevention of Acute Graft-Versus-Host Disease (GVHD) Following Myeloablative Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) (MK-7110-002)

Leukemia | Hematopoietic Stem Cell Transplantation | Graft Versus Host Disease

United States

Clinical Trials on CD34 Selected Peripheral Blood Stem Cell Graft

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Bahamas

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations